Patents by Inventor Catherine M. Bitler

Catherine M. Bitler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OLIVE COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS
    Publication number: 20230296618
    Abstract: A method of treating an inflammatory condition with a hydroxytyrosol-rich composition. Improvement is monitored as a reduction in the levels of a biochemical marker such as homocysteine or C-reactive protein. The composition may be administered in an amount and for a period sufficient to effect a drop in the level of the biochemical marker.
    Type: Application
    Filed: February 10, 2023
    Publication date: September 21, 2023
    Inventors: Kathleen Matt, Catherine M. Bitler, Roberto Crea
  • OLIVE COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS
    Publication number: 20200319198
    Abstract: A method of treating an inflammatory condition with a hydroxytyrosol-rich composition. Improvement is monitored as a reduction in the levels of a biochemical marker such as homocysteine or C-reactive protein. The composition may be administered in an amount and for a period sufficient to effect a drop in the level of the biochemical marker.
    Type: Application
    Filed: April 21, 2020
    Publication date: October 8, 2020
    Inventors: Kathleen Matt, Catherine M. Bitler, Roberto Crea
  • Vegetation water composition for treatment of inflammatory skin conditions
    Patent number: 9789149
    Abstract: Compositions obtained from vegetation water from olives and methods for treating patients suffering from an inflammatory skin disease with the compositions are described. Included are hydroxytyrosol rich compounds obtained from olive vegetation water.
    Type: Grant
    Filed: July 19, 2005
    Date of Patent: October 17, 2017
    Assignee: CreAgri, Inc.
    Inventors: Fujio Numano, Roberto Crea, Tokuko S. Wiedemann, Catherine M. Bitler
  • EXTRACTS
    Publication number: 20140127332
    Abstract: Novel compositions which are useful in the treatment of mammals for the reduction of inflammation, especially in the gut, and which comprise an aqueous extract of an agricultural product. Preferred compositions comprise an aqueous extract of olive, or an aqueous extract of ginger. The compositions can optionally contain an aqueous extract of chamomile and/or an aqueous extract of artichoke and/or an aqueous extract of cinnamon.
    Type: Application
    Filed: November 8, 2012
    Publication date: May 8, 2014
    Inventor: Catherine M. BITLER
  • OLIVE COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS
    Publication number: 20110257117
    Abstract: A method of treating an inflammatory condition with a hydroxytyrosol-rich composition. Improvement is monitored as a reduction in the levels of a biochemical marker such as homocysteine or C-reactive protein. The composition may be administered in an amount and for a period sufficient to effect a drop in the level of the biochemical marker.
    Type: Application
    Filed: June 8, 2011
    Publication date: October 20, 2011
    Inventors: Kathleen Matt, Catherine M. Bitler, Roberto Crea
  • Olive Compositions and Methods for Treating Inflammatory Conditions
    Publication number: 20080300198
    Abstract: A method of treating an inflammatory condition with a hydroxytyrosol-rich composition. Improvement is monitored as a reduction in the levels of a biochemical marker such as homocysteine or C-reactive protein. The composition may be administered in an amount and for a period sufficient to effect a drop in the level of the biochemical marker.
    Type: Application
    Filed: August 9, 2005
    Publication date: December 4, 2008
    Inventors: Kathleen Matt, Catherine M. Bitler
  • Compositions for treating ischemia-related neuronal damage
    Publication number: 20040072862
    Abstract: Compounds, pharmaceutical compositions, and methods of use are described which are effective in inhibiting cell death, particularly apoptotic cell death. The compositions may be used for prevention and treatment of injuries associated with cell death, including ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation.
    Type: Application
    Filed: January 29, 2003
    Publication date: April 15, 2004
    Inventors: Catherine M. Bitler, Paul Wood, D. Timothy Anstine, Anke Meyer-Franke, Qi Zhao, Mohamed A. Khan
  • Bis-benzimidazole compounds and analogs thereof for inhibiting cell death
    Patent number: 6541486
    Abstract: Compounds, pharmaceutical compositions, and methods of use are described which are effective in inhibiting cell death, particularly apoptotic cell death. The compositions may be used for prevention and treatment of injuries associated with cell death, including ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: April 1, 2003
    Assignee: Elan Pharma International Ltd.
    Inventors: Catherine M. Bitler, Paul L. Wood, Duran T. Anstine, Anke Meyer-Franke, Qi Zhao, Mohamed A. Khan
  • Methods for selecting compounds for treating ischemia-related cellular damage
    Publication number: 20020102597
    Abstract: A method of screening for and treating subjects with a therapeutically effective amount of a compound that is effective in reducing cellular damage related to an ischemic condition, such as stroke or glaucoma. Test compounds are selected and therapeutically effective amount determined based on the relative efficacy of test compounds in preventing cell death in primary cultures of excitable cells, such as retinal ganglion cells, in vitro.
    Type: Application
    Filed: February 12, 2002
    Publication date: August 1, 2002
    Inventors: Catherine M. Bitler, Anke Meyer-Franke, Paul Wood
  • Method for selecting compounds for treating ischemia-related cellular damage
    Patent number: 6379882
    Abstract: A method of screening for and treating subjects with a therapeutically effective amount of a compound that is effective in reducing cellular damage related to an ischemic condition, such as stroke or glaucoma. Test compounds are selected and therapeutically effective amount determined based on the relative efficacy of test compounds in preventing cell death in primary cultures of excitable cells, such as retinal ganglion cells, in vitro.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: April 30, 2002
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Catherine M. Bitler, Anke Meyer-Franke, Paul Wood